 |
|
|
| |
Combination of an FXR Agonist and an ACC Inhibitor
Increases Antifibrotic Efficacy in Rodent Models of NASH
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Jamie Bates, Kathy Liu, David Hollenback, Anna Zagorska, Grant Budas, John T. Liles, Henry Liu, Saritha Kusam, Robert Brockett, David Newstrom, Igor Mikaelian, Ting Wang, Adrian S. Ray, David G. Breckenridge
Gilead Sciences, Inc., Foster City, California, USA
References
1. Hambruch E, et al. Nucl Receptor Res 2016;3; 2. Abu-Elheiga L, et al. Proc Natl Acad Sci USA 2005;102:12011-6; 3. Mao J, et al. Proc Natl Acad Sci USA 2006;103:8552-7; 4. Harriman G, et al. Proc Natl Acad Sci USA 2016;113:E1796-805; 5. Lawitz EJ, et al. EASL 2017, abstr LBO-002; 6. Loomba R, et al. AASLD 2017, abstr LB-9; 7. Charlton M, et al. Am J Physiol Gastrointest Liver Physiol 2011;301:G825-34.
|
| |
|
|
|
|
|
